Fiscal التقويم فعلي إجماع السابق تاريخ




Eps تغيير تاريخ
AbbVie USD 2.65 0.06 2026-03
Amgen USD 5.15 0.14 2026-03
Anika Therapeutics USD 0.13 0.35 2025-12
Arrowhead Research USD -0.93 1.15 2026-03
AstraZeneca USD 2.58 0.46 2026-03
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
Biogen USD 3.57 1.58 2026-03
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Gilead Sciences USD 2.03 0.17 2026-03
GlaxoSmithKline GBP 0.43 0.17 2026-03
Halozyme Therapeutics USD 1.6 1.84 2026-03
Heron Therapeutics USD -0.02 0.02 2025-12
Immunic USD -0.1 0.03 2025-12
Incyte USD 1.81 0.01 2026-03
Insmed USD -0.76 0.78 2026-03
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
J&J USD 2.7 0.24 2026-03
Karyopharm Therapeutics USD -2.22 2.07 2025-12
Ligand Pharmaceuticals USD 1.63 0.39 2026-03
Merck USD -1.28 3.32 2026-03
Neurocrine Biosciences USD 1.94 0.06 2026-03
Novartis USD 1.99 0.04 2026-03
Novavax USD 0.13 0.59 2025-12
Pfizer USD 0.75 0.09 2026-03
PTC Therapeutics USD -0.03 1.64 2026-03
Roche Holding CHF 8.37 2.95 2025-12
Sarepta Therapeutics USD 3.16 6.74 2026-03
Vertex Pharmaceuticals USD 4.47 0.56 2026-03